Your Web Site
Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
PRNEWSWIRE SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Vical Incorporated announced today that the company has completed enrollment of subjects in a Phase 2 trial of its therapeutic DNA vaccine designed to prevent...

